More effective therapies and better prevention and control of chronic illness will result in fewer and shorter hospital stays and a shift from expensive reactive care to prevention. Though progress has been slow since President Barak Obama announced the Precision Medicine Initiative, it is believed that ultimately it has the potential to improve both the quality and quantity of a patient's life which will also have a knock-on effect on the economies of the healthcare system. The first step in this process was taken by the US Food and Drug Administration (FDA) when they approved the use of CRISPR technology for gene editing back in 2013.
Though progress has been slow since President Barak Obama announced the Precision Medicine Initiative, it is believed that ultimately it has the potential to improve both the quality and quantity of a patient's life which will also have a knock-on effect on the economies of the healthcare system. The first step in this process was taken by the US Food and Drug Administration (FDA) when they approved the use of CRISPR technology for gene editing back in 2013.